Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has announced its 2024 Action Plan focused on improving quality, efficiency, and prioritizing shareholder returns, in line with the State Council’s directives and the Shanghai Stock Exchange’s initiative. The plan aims to ensure the company’s high-quality development and enhance value for shareholders. The Board takes full responsibility for the announcement’s accuracy and completeness.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.
